Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review
Joint Authors
Source
Issue
Vol. 2016, Issue 2016 (31 Dec. 2015), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-12-29
Country of Publication
Egypt
No. of Pages
7
Abstract EN
Stem cell transplantation is a potential therapeutic option to regenerate damaged myocardium and restore function after infarct.
Current research is focused on the use of allogeneic mesenchymal stem cells (MSCs) due to their unique immunomodulatory characteristics and ability to be harvested from young and healthy donors.
Both animal and human studies support the immunoprivileged state of MSCs and even demonstrate improvements in cardiac function after transplantation.
This research continues to be a topic of interest, as advances will ultimately enable the clinical use of these universal cells for therapy after a myocardial infarction.
Updated in vitro, in vivo, and clinical trial studies are discussed in detail in the following review.
American Psychological Association (APA)
Faiella, Whitney& Atoui, Rony. 2015. Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review. Stem Cells International،Vol. 2016, no. 2016, pp.1-7.
https://search.emarefa.net/detail/BIM-1116147
Modern Language Association (MLA)
Faiella, Whitney& Atoui, Rony. Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review. Stem Cells International Vol. 2016, no. 2016 (2015), pp.1-7.
https://search.emarefa.net/detail/BIM-1116147
American Medical Association (AMA)
Faiella, Whitney& Atoui, Rony. Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review. Stem Cells International. 2015. Vol. 2016, no. 2016, pp.1-7.
https://search.emarefa.net/detail/BIM-1116147
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1116147